Literature DB >> 27459664

Retinal Ganglion Cell and Inner Plexiform Layer Loss Correlate with Visual Acuity Loss in LHON: A Longitudinal, Segmentation OCT Analysis.

Stephen J Moster1, Mark L Moster1, Molly Scannell Bryan2, Robert C Sergott1.   

Abstract

PURPOSE: Describe changes in the retina as vision loss progresses in Leber's Hereditary Optic Neuropathy (LHON) using spectral-domain optical coherence tomography (SD-OCT) autosegmentation, and determine if relationship exists between retinal changes and vision loss.
METHODS: From patient records we identified nine LHON patients who underwent periodic neuro-ophthalmologic examinations and high-resolution SD-OCT as part of their care. We describe the impact of LHON progression on each retinal layer, and the relationship between these structural changes and visual acuity using generalized estimating equations and nonparametric tests.
RESULTS: The thickness of the ganglion cell layer (GCL) and inner plexiform layer (IPL) decreased immediately or soon after symptom onset, and this decrease was associated with worsening vision: in the GCL a 1-mm3 volume loss was associated with a 3.2 increase in logMAR visual acuity (95% confidence interval [CI]: 2.1-4.1); in the IPL a 1-mm3 volume loss was associated with a 4.9 increase in visual acuity (95%CI: 6.5-3.2). The retinal nerve fiber layer (RNFL) also thinned, but not until after the GCL and IPL, and only in the papillomacular bundle (PMB) and temporal layers was thinning associated with vision loss.
CONCLUSIONS: For the first time these analyses describe a structure-function relationship between the retinal changes that occur in LHON patients as their disease progresses and vision worsens. The structural changes in the GCL, IPL, and RNFL preceded structural changes in the other retinal layers. This analysis suggests that the first 6 months after diagnosis define a target for therapeutic intervention, and this can inform treatment guidelines for ongoing therapeutic trials.

Entities:  

Mesh:

Year:  2016        PMID: 27459664     DOI: 10.1167/iovs.15-17328

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

Review 1.  Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development.

Authors:  Charles B Wright; Steven M Becker; Lucie A Low; Danilo A Tagle; Paul A Sieving
Journal:  J Ocul Pharmacol Ther       Date:  2019-06-05       Impact factor: 2.671

2.  Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules.

Authors:  Alfred K Yu; Sandipan Datta; Marissa Z McMackin; Gino A Cortopassi
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

3.  The Natural History of Leber's Hereditary Optic Neuropathy in an Irish Population and Assessment for Prognostic Biomarkers.

Authors:  Kirk A J Stephenson; Joseph McAndrew; Paul F Kenna; Lorraine Cassidy
Journal:  Neuroophthalmology       Date:  2022-03-02

4.  Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension.

Authors:  Vivek Vijay; Susan P Mollan; James L Mitchell; Edward Bilton; Zerin Alimajstorovic; Keira A Markey; Anthony Fong; Jessica K Walker; Hannah S Lyons; Andreas Yiangou; Georgios Tsermoulas; Kristian Brock; Alexandra J Sinclair
Journal:  JAMA Ophthalmol       Date:  2020-12-01       Impact factor: 7.389

5.  Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber's hereditary optic neuropathy.

Authors:  Jeffrey N Weiss; Steven Levy; Susan C Benes
Journal:  Neural Regen Res       Date:  2016-10       Impact factor: 5.135

6.  Electrophysiological and Structural Changes in Chinese Patients with LHON.

Authors:  Min Wang; Hong Guo; Shiying Li; Gang Wang; Yanling Long; Xiaohong Meng; Bo Liu; Yong Liu; Anthony G Robson; Zheng Qin Yin
Journal:  J Ophthalmol       Date:  2020-03-30       Impact factor: 1.909

7.  Folic Acid Fortification Prevents Morphological and Behavioral Consequences of X-Ray Exposure During Neurulation.

Authors:  Kai Craenen; Mieke Verslegers; Zsuzsanna Callaerts-Vegh; Livine Craeghs; Jasmine Buset; Kristof Govaerts; Mieke Neefs; Willy Gsell; Sarah Baatout; Rudi D'Hooge; Uwe Himmelreich; Lieve Moons; Mohammed Abderrafi Benotmane
Journal:  Front Behav Neurosci       Date:  2021-01-08       Impact factor: 3.558

8.  Cross-Sectional Analysis of Baseline Visual Parameters in Subjects Recruited Into the RESCUE and REVERSE ND4-LHON Gene Therapy Studies.

Authors:  Mark L Moster; Robert C Sergott; Nancy J Newman; Patrick Yu-Wai-Man; Valerio Carelli; Molly Scannell Bryan; Gerard Smits; Valérie Biousse; Catherine Vignal-Clermont; Thomas Klopstock; Alfredo A Sadun; Adam A DeBusk; Michele Carbonelli; Rabih Hage; Siegfried Priglinger; Rustum Karanjia; Laure Blouin; Magali Taiel; Barrett Katz; José Alain Sahel
Journal:  J Neuroophthalmol       Date:  2021-09-01       Impact factor: 4.415

9.  Observation of Peripapillary Choroidal Vascularity in Natural Disease Course and After Gene Therapy for Leber's Hereditary Optic Neuropathy.

Authors:  Jingwen Jiang; Gongpeng Sun; Qingmei Miao; Bin Li; Dan Wang; Jiajia Yuan; Changzheng Chen
Journal:  Front Med (Lausanne)       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.